Humacyte annual shares outstanding
2020
2021
2022
2023
2024
2025
Humacyte Shares Outstanding History (HUMA)
Humacyte reported 193.0M shares outstanding at the end of fiscal 2025.
View full Humacyte company overviewHumacyte annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 193.0M | 63.0M | +48.43% |
| 2024 | 2024-12-31 | 130.0M | 26.4M | +25.42% |
| 2023 | 2023-12-31 | 103.7M | 444,715 | +0.43% |
| 2022 | 2022-12-31 | 103.2M | 225,367 | +0.22% |
| 2021 | 2021-12-31 | 103.0M | 97.2M | +1669.09% |
| 2020 | 2020-12-31 | 5.8M | — | — |
Humacyte quarterly shares outstanding
Q4.20
As of Aug 26, 2021
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 277.8M | 121.5M | +77.69% |
| Q1 2026 | 2026-03-31 | 222.0M | 66.9M | +43.13% |
| Q4 2025 | 2025-12-31 | 193.0M | 63.0M | +48.43% |
| Q3 2025 | 2025-09-30 | 158.8M | 39.0M | +32.54% |
| Q2 2025 | 2025-06-30 | 156.3M | 37.0M | +31.00% |
| Q1 2025 | 2025-03-31 | 155.1M | 36.0M | +30.26% |
| Q4 2024 | 2024-12-31 | 130.0M | 26.4M | +25.42% |
| Q3 2024 | 2024-09-30 | 119.8M | 16.4M | +15.83% |
| Q2 2024 | 2024-06-30 | 119.3M | 15.9M | +15.41% |
| Q1 2024 | 2024-03-31 | 119.1M | 15.8M | +15.25% |
| Q4 2023 | 2023-12-31 | 103.7M | 444,715 | +0.43% |
| Q3 2023 | 2023-09-30 | 103.5M | 362,068 | +0.35% |
| Q2 2023 | 2023-06-30 | 103.4M | 401,445 | +0.39% |
| Q1 2023 | 2023-03-31 | 103.3M | 324,599 | +0.32% |
| Q4 2022 | 2022-12-31 | 103.2M | 225,367 | +0.22% |
| Q3 2022 | 2022-09-30 | 103.1M | 95,384 | +0.09% |
| Q2 2022 | 2022-06-30 | 103.0M | 3,419 | +0.00% |
| Q1 2022 | 2022-03-31 | 103.0M | 97.2M | +1669.11% |
| Q4 2021 | 2021-12-31 | 103.0M | — | — |
| Q3 2021 | 2021-09-30 | 103.0M | — | — |
| As of Aug 26, 2021 | 2021-08-26 | 103.0M | — | — |
| Q4 2020 | 2020-12-31 | 5.8M | — | — |
Humacyte shares outstanding trends
Over the last five reported fiscal years, Humacyte's shares outstanding moved from 5.8M to 193.0M, a change of 187.2M. The latest reported quarter, Q2 2026, shows 277.8M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Humacyte filings at SEC.gov ↗